Schizophrenia Research
Volume 77, Issue 1 , Pages 107-109, 1 September 2005

Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care

  • Hélène Verdoux

      Affiliations

    • Corresponding Author InformationCorresponding author. Hopital Charles Perrens 121 rue de la Bechade 33076 Bordeaux Cedex, France. Tel.: +33 556 56 17 32; fax: +33 556 56 35 46.

INSERM U 657, IFR99 of Public Health, Université Victor Segalen Bordeaux2, France

Received 24 January 2005; accepted 4 February 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(05)00066-6

doi:10.1016/j.schres.2005.02.001

Schizophrenia Research
Volume 77, Issue 1 , Pages 107-109, 1 September 2005

Article Tools